Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Prostatic Neoplasms × radium Ra 223 dichloride × Sarcoma × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 39 Sarcoma 1

Conditions

Prostatic Neoplasms 1 Bone Neoplasms 1

Interventions

Gemcitabine 4 Cryosurgery 3 Biopsy 3 pembrolizumab 2 eribulin 2 durvalumab 2 balstilimab 2 atezolizumab 2 aflibercept 2 Trastuzumab 2 Taxes 2 Specimen Handling 2 Radiotherapy 2 Radiosurgery 2 Radiation 2 Magnetic Resonance Spectroscopy 2 Letrozole 2 Irinotecan 2 Gene Expression Profiling 2 Fulvestrant 2 Docetaxel 2 Cisplatin 2 Blood Specimen Collection 2 130-nm albumin-bound paclitaxel 2 tremelimumab 1 trastuzumab deruxtecan 1 trastuzumab biosimilar HLX02 1 tivozanib 1 talazoparib 1 spartalizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04681144 2023-10-26

QOLRAD

Bayer

GenitourinarySarcoma

Bone Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡